Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc (NASDAQ: AMED) provides essential home healthcare, hospice, and high-acuity care services across the United States. This news hub offers investors and industry professionals direct access to verified corporate announcements and financial updates from the home healthcare leader.
Track material developments including quarterly earnings reports, regulatory filings, clinical program expansions, and strategic partnerships. Our curated collection features official press releases, SEC disclosures, and market-moving updates - all organized chronologically for efficient research.
Key content categories include financial performance updates, Medicare/Medicaid compliance changes, care center acquisitions, leadership appointments, and clinical quality initiatives. Bookmark this page for real-time access to operational milestones that shape AMED's position in the $300B home healthcare market.
For stakeholders monitoring the shift toward value-based care models, this resource simplifies tracking of Amedisys' evolving service offerings and regulatory compliance status. Visit regularly to stay informed about critical developments affecting one of America's largest home health providers.
Amedisys, Inc. (NASDAQ: AMED) reported Q4 2021 net service revenue of $559.3 million, up $8.6 million from Q4 2020. However, net income decreased to $34.0 million, or $1.04 per diluted share, down from $45.2 million, or $1.36, in the previous year. For the full year, revenue climbed to $2,214.1 million, with net income rising to $209.1 million. The company anticipates 2022 adjusted net service revenue between $2.330 billion and $2.365 billion, amid ongoing COVID-19 impacts. The CEO expressed optimism about future growth opportunities as the company adapts to evolving healthcare needs.
Virginia Mason Franciscan Health has partnered with Contessa, an Amedisys company (NASDAQ: AMED), to launch Home Recovery Care, enabling patients to receive hospital-level care at home. This initiative aims to enhance access to high-acuity care, increase inpatient capacity, and lower overall healthcare costs. The program, starting at St. Joseph Medical Center in Tacoma, will initially serve Medicare fee-for-service patients and includes remote monitoring, nursing visits, and telehealth consultations. Historically, this care model has reduced readmission rates by 44% and hospital stay lengths by 35%.
Amedisys, Inc. (NASDAQ: AMED) announced the acquisition of home health assets from AssistedCare Home Health, enhancing its services in North Carolina. The deal, set to close on or around April 1, 2022, will allow Amedisys to serve over 1.5 million Medicare enrollees in the state. AssistedCare's home health operations will transition to Amedisys, promoting a strategy focused on aging in place. Post-acquisition, Amedisys will encompass 350 care centers across 34 states, with approximately 74,000 daily patients, significantly expanding its community reach.
Amedisys, Inc. (AMED) has signed a definitive agreement to acquire Evolution Health, LLC, enhancing its home health services. The acquisition, expected to close in the first half of 2022, will allow Amedisys to serve over 1.9 million Medicare enrollees in Texas and over 800,000 in Ohio, increasing its network to 346 care centers across 34 states. This move aims to strengthen Amedisys' position as a quality home healthcare provider, expanding patient access and aligning with existing hospice services.
Amedisys, Inc. (NASDAQ: AMED) will report its fourth quarter and full year results for 2021 on February 23, 2022, after market close. An investor conference call is scheduled for February 24, 2022, at 11:00 a.m. ET. Participants can join by dialing (877) 524-8416 or (412) 902-1028. A replay will be available until March 24, 2022. A live webcast will also be accessible on the Company's Investor Relations website. Amedisys focuses on delivering personalized home health, hospice, personal care, and higher acuity care services nationwide.
Amedisys (NASDAQ: AMED) announced the retirement of CEO Paul Kusserow effective April 15, 2022, after seven years in the role. He will remain as Chairman of the Board. Chris Gerard, currently President and COO, will succeed him as CEO. Under Kusserow’s leadership, Amedisys improved its Home Health Quality of Patient Care Star score from 3.5 to 4.33 and expanded its business significantly, increasing market cap from $900 million to over $5.3 billion. The leadership transition is expected to be seamless, with Gerard highlighting growth opportunities ahead.
Amedisys, a leading provider of home health and hospice services, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12 at 3:45 p.m. EST. The presentation will feature key executives including Paul B. Kusserow, Chris Gerard, and Scott Ginn. Interested parties can access the live webcast through the company's website. Amedisys focuses on delivering personalized patient care across various service lines, catering to over 418,000 patients annually. The company has a significant presence, with approximately 21,000 employees and 529 care centers nationwide.
Amedisys, a prominent provider of in-home healthcare, announced key presentations at the Bank of America Securities 2021 Virtual Healthcare Conference. Scheduled for December 6 at 9:00 a.m. Eastern, the presentation will feature Paul B. Kusserow, Chris Gerard, and Scott Ginn. Amedisys specializes in home health, hospice, and personal care services, partnering with over 2,900 hospitals and 78,000 physicians. The company, headquartered in Baton Rouge, serves over 418,000 patients annually, employing around 21,000 staff across 529 care centers in 38 states.
Amedisys, a top provider of home health services, announced its participation in the Stephens Annual Investment Conference on December 3rd at 10:00 AM Eastern. Presenters include Paul B. Kusserow, CEO, Chris Gerard, COO, and Scott Ginn, CFO. The event can be accessed via a live webcast on Amedisys' investor relations website. With over 21,000 employees and 529 care centers nationwide, Amedisys delivers personalized care to over 418,000 patients annually, partnering with more than 2,900 hospitals and 78,000 physicians across the U.S.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
